Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program
NASDAQ | TSX: ACB
EDMONTON, AB, June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing program in Canada. As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program has increased from $40,000 to $60,000 CAD for Aurora patients through AuroraMedical.com.
'As over half of the country's adult population fits within this income threshold, our compassionate pricing program represents the most accessible, inclusive pricing plan to access medical cannabis in Canada,' says Geoff Hoover, SVP of Canadian Commercial at Aurora. 'We're committed to breaking down barriers to access high quality medical cannabis, and this change empowers more patients to explore different treatment options at pricing they can afford.'
The changes to the compassionate pricing program are available alongside new medical cannabis products, including:
In addition to the compassionate pricing program, Aurora offers resources to seniors, pediatric patients, veterans, first responders, and others seeking care through medical cannabis. Patients can visit www.auroramedical.com for more information and to connect with the Aurora client care team for further support.
About Aurora Cannabis Inc.
Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the symbol 'ACB'.
Forward Looking Information
This news release includes statements containing certain 'forward-looking information' within the meaning of applicable securities law ('forward-looking statements'). Forward-looking statements are frequently characterized by words such as 'plan', 'continue', 'expect', 'project', 'intend', 'believe', 'anticipate', 'estimate', 'may', 'will', 'potential', 'proposed' and other similar words, or statements that certain events or conditions 'may' or 'will' occur. Forward-looking statements in this news release include, but are not limited to, statements regarding the Company's expanded compassionate pricing program, and associated benefits for patients.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States; the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading 'Risk Factors' in the Company's annual information form dated June 17, 2025 (the 'AIF') and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
View original content to download multimedia: https://www.prnewswire.com/news-releases/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program-302491509.html
SOURCE Aurora Cannabis Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Big News for Roku Investors (and It's Exactly Why I Decided Against Selling)
Roku is trying to provide an advertising capability that few (if any) have ever been able to offer. However, the platform doesn't seem to have impressed advertisers in recent years, This is a troubling trend that needs to soon change in order to jump-start the business. 10 stocks we like better than Roku › There are multiple reasons to believe that stocks are overvalued right now, generally speaking, motivating me to move on from some old duds in my portfolio. For starters, consider the market for initial public offerings (IPOs). Companies usually wait to go public until market conditions heat up. High stock valuations allow IPO companies to raise more money. After below-average IPO years in 2022, 2023, and 2024, this year is shaping up to be above-average for new listings. The rise in IPO stocks in 2025 suggests that stock market valuations are high. And this suggestion can be corroborated further. According to YCharts, the price-to-earnings (P/E) ratio for the S&P 500 is 28, well above its 10-year average of 25. Some investors may use this information to "time the market," selling all of their stocks. I believe that's the wrong takeaway -- there's no telling what will happen with the market next. But for me, I have stocks in my portfolio that I'd like to move on from. In my view, now is as good a time as any to sell these, considering the stock market is potentially overvalued. I recently gave connected-TV platform company Roku (NASDAQ: ROKU) a hard look. I started buying shares in 2020 and continued buying into 2022. My entire position is down about 15% as of this writing, even though the S&P 500 has risen dramatically during my holding period. But I ultimately decided to keep holding for one key reason. It's early. But so far, I'm happy with my choice. On June 16, Roku secured a deal with Amazon (NASDAQ: AMZN). And it underscores why I still haven't sold Roku stock yet. For eight consecutive quarters, Roku has sold its hardware devices at a gross loss -- it sells them for less than it costs to make them. It does this because it's more interested in taking market share and becoming an advertising-technology (adtech) titan in connected TV (CTV). When it comes to adtech, TV screens are the most desirable advertising medium, and Roku powers TVs in over 90 million households. Not only is the video format attractive to advertisers, but Roku has an interesting value proposition: It can "close the loop" in advertising. Over the years, Roku has struck some interesting partnerships with companies such as Kroger, Walmart, and Cox Automotive. Take the Cox Automotive partnership for illustration. It owns the popular Kelley Blue Book platform. Through the partnership, Roku can show marketers how viewers are really responding to vehicle ads. If they see an ad and then head over to Kelley Blue Book for better info, that's an important data point for advertisers. In this scenario, Roku and Cox Automotive work together to close the loop as much as possible. Roku's partnerships with Kroger and Walmart can do similar things. Consumer brands could advertise on Roku, know who saw an ad, and know whether they bought anything at Kroger or Walmart as a result. Assuming Roku can demonstrate a high return on advertising spending, demand for its platform should soar, allowing it to command better advertising rates. Now Roku is partnering with Amazon, and the potential is similar. Amazon is the largest e-commerce company in the world and perhaps knows more about consumers than any other retailer. This makes Amazon's advertising solutions quite popular and explains how its ads business scaled so quickly. Through the new partnership, Roku and Amazon hope to deliver a win-win. It's a potential win for Roku because advertisers will have data from Amazon and can better target Roku's viewers. It's a potential win for Amazon also because (in spite of investors' concerns about Amazon's Fire TV) Roku remains the top player in the space. In short, I believe Roku's partnership with Amazon is big news for investors, and it's exactly the kind of news that's kept me as a shareholder. But allow me to contextualize the news a little more. Roku's potential has been sky-high, but it has, nevertheless, been a disappointment in recent years. Roku generated higher average revenue per user (APRU) in 2022 than it did in 2024. And management doesn't even break out this metric anymore, suggesting the numbers are still disappointing. But viewership has increased dramatically. This alone should have lifted ARPU. The only logical explanation is that advertising demand simply hasn't grown as it should, in spite of what Roku's adtech capabilities can theoretically provide. Roku's partnership with Amazon is expected to officially launch before the end of the year. If the partnership can't materially improve Roku's monetization at some point in 2026, then I don't know what will. Failure to see a substantial improvement with Roku at some point in 2026 could suggest it's finally time to move on from this once-promising stock. Before you buy stock in Roku, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Roku wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Jon Quast has positions in Roku. The Motley Fool has positions in and recommends Amazon, Roku, and Walmart. The Motley Fool recommends Kroger. The Motley Fool has a disclosure policy. Big News for Roku Investors (and It's Exactly Why I Decided Against Selling) was originally published by The Motley Fool Sign in to access your portfolio
Hamilton Spectator
an hour ago
- Hamilton Spectator
Lululemon sues Costco for selling alleged dupes of its products
Lululemon Athletica Canada Inc. is accusing Costco Wholesale Corp. of infringing on its intellectual property by selling knockoffs of some of its most popular products. A lawsuit filed in a California court recently alleges Costco sells dupes of Lululemon's Scuba hoodies and sweatshirts, Define jackets and ABC pants. Some of the alleged fakes Vancouver-based Lululemon identified are sold under Costco's private label Kirkland, but others are made by manufacturers Danskin, Jockey and Spyder. 'Some customers incorrectly believe these infringing products are authentic Lululemon apparel while still other customers specifically purchase the infringing products because they are difficult to distinguish from authentic Lululemon products, particularly for downstream purchasers or observers,' the lawsuit says. Lululemon alleges these scenarios take advantage of patents it holds, as well as the reputation and goodwill it has built with customers. In its 49-page court filing, Lululemon says it tried to address the dupes by sending Costco cease and desist letters but is now asking a court to step in. Lululemon has requested the matter be heard by a jury trial, which it wants to order Costco to cease manufacturing, importing, marketing and selling the alleged dupes. It also wants the Washington-based retailer to remove any instances where it was advertising alleged dupes online or in print and is asking the court to require Costco to cover any lost profits Lululemon incurred from the products. Costco did not immediately respond to a request for comment. It has yet to file a response to Lululemon's lawsuit. Dupes have become incredibly popular in recent years as shoppers looked to cope with inflation and a global trade war by seeking products mimicking the originals made by name brands. The phenomenon has gained traction online in particular, with social media accounts sharing the best dupes they've found. While knock-off cosmetics are especially popular, Lululemon has also become a target because it sells its athletic wear at higher prices, which some customers find unattainable. The lawsuit comes weeks after Lululemon said it would try to weather new and possibly incoming tariffs with price increases that will be 'modest in nature' and applied only to a 'small' portion of its products. The brand has been working to bounce back from a lack of newness that disappointed consumers last year and earlier this year. Newness — how fresh a brand's products and styles appear to consumers — is one of the key ways retailers draw in customers. This report by The Canadian Press was first published June 29, 2025. Companies in this story: (TSX:LULU)
Yahoo
an hour ago
- Yahoo
BGM Group Ltd.'s (NASDAQ:BGM) top holders are insiders and they are likely disappointed by the recent 8.4% drop
Significant insider control over BGM Group implies vested interests in company growth A total of 3 investors have a majority stake in the company with 57% ownership Past performance of a company along with ownership data serve to give a strong idea about prospects for a business AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. A look at the shareholders of BGM Group Ltd. (NASDAQ:BGM) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are individual insiders with 73% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company. And following last week's 8.4% decline in share price, insiders suffered the most losses. Let's take a closer look to see what the different types of shareholders can tell us about BGM Group. View our latest analysis for BGM Group Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing. As you can see, institutional investors have a fair amount of stake in BGM Group. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of BGM Group, (below). Of course, keep in mind that there are other factors to consider, too. Hedge funds don't have many shares in BGM Group. Our data shows that Low Thia Yang is the largest shareholder with 26% of shares outstanding. For context, the second largest shareholder holds about 17% of the shares outstanding, followed by an ownership of 14% by the third-largest shareholder. A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 57% stake. While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. It seems that insiders own more than half the BGM Group Ltd. stock. This gives them a lot of power. Given it has a market cap of US$2.2b, that means insiders have a whopping US$1.6b worth of shares in their own names. Most would argue this is a positive, showing strong alignment with shareholders. You can click here to see if they have been selling down their stake. The general public, who are usually individual investors, hold a 18% stake in BGM Group. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. It's always worth thinking about the different groups who own shares in a company. But to understand BGM Group better, we need to consider many other factors. To that end, you should learn about the 2 warning signs we've spotted with BGM Group (including 1 which is significant) . If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
